Cargando…

Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice

BACKGROUND: Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a protectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xueping, Lu, Fuer, Li, Lingli, Li, Jingbin, Luo, Jinlong, Zhang, Siyi, Liu, Xinqiao, Chen, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357370/
https://www.ncbi.nlm.nih.gov/pubmed/30704457
http://dx.doi.org/10.1186/s12906-019-2443-6
_version_ 1783391771472953344
author Yang, Xueping
Lu, Fuer
Li, Lingli
Li, Jingbin
Luo, Jinlong
Zhang, Siyi
Liu, Xinqiao
Chen, Guang
author_facet Yang, Xueping
Lu, Fuer
Li, Lingli
Li, Jingbin
Luo, Jinlong
Zhang, Siyi
Liu, Xinqiao
Chen, Guang
author_sort Yang, Xueping
collection PubMed
description BACKGROUND: Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a protective role in pancreatic islets. METHODS: Drug testing and mechanism analyses were performed on mice treated with three concentrations of WMW (4800, 9600, and 19,200 mg/kg/bw) for four consecutive weeks. Blood was collected from both db/db and wild-type mice to determine fasting blood glucose (FBG) and serum insulin levels. The expression of proteins related to apoptosis, cysteinyl aspartate-specific proteinase 12 (caspase-12) and B-cell leukemia 2 (Bcl-2), was measured by western blot. Interleukin-1β (IL-1β), interleukin-18 (IL-18), monocyte chemoattractant protein-1α (MCP-1α), and tumor necrosis factor-α (TNF-α) in the pancreas were tested with enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry staining of F4/80 was performed to measure the pancreatic infiltration of macrophages. Western blot and immunofluorescence staining of the NLRP3 inflammasome were used to measure the expression of proteins related to apoptosis and inflammation. RESULTS: WMW dose-dependently reduced FBG and promoted serum insulin secretion in db/db mice compared to the wild-type controls. WMW protected pancreatic β cells with a pattern of decreasing caspase-12 and increasing Bcl-2 expression. WMW also reversed the upregulated production of IL-1β, IL-18, MCP-1α, and macrophage-specific surface glycoprotein F4/80 in diabetic mice. In addition, the protein expression levels of NLRP3 inflammasome components NLRP3, ASC, and caspase-1 (P20) were higher in db/db mice than in wild-type controls. CONCLUSIONS: WMW inhibits the activation of the NLRP3 inflammasome to protect pancreatic β cells and prevent type 2 diabetes mellitus development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-019-2443-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6357370
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63573702019-02-07 Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice Yang, Xueping Lu, Fuer Li, Lingli Li, Jingbin Luo, Jinlong Zhang, Siyi Liu, Xinqiao Chen, Guang BMC Complement Altern Med Research Article BACKGROUND: Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a protective role in pancreatic islets. METHODS: Drug testing and mechanism analyses were performed on mice treated with three concentrations of WMW (4800, 9600, and 19,200 mg/kg/bw) for four consecutive weeks. Blood was collected from both db/db and wild-type mice to determine fasting blood glucose (FBG) and serum insulin levels. The expression of proteins related to apoptosis, cysteinyl aspartate-specific proteinase 12 (caspase-12) and B-cell leukemia 2 (Bcl-2), was measured by western blot. Interleukin-1β (IL-1β), interleukin-18 (IL-18), monocyte chemoattractant protein-1α (MCP-1α), and tumor necrosis factor-α (TNF-α) in the pancreas were tested with enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry staining of F4/80 was performed to measure the pancreatic infiltration of macrophages. Western blot and immunofluorescence staining of the NLRP3 inflammasome were used to measure the expression of proteins related to apoptosis and inflammation. RESULTS: WMW dose-dependently reduced FBG and promoted serum insulin secretion in db/db mice compared to the wild-type controls. WMW protected pancreatic β cells with a pattern of decreasing caspase-12 and increasing Bcl-2 expression. WMW also reversed the upregulated production of IL-1β, IL-18, MCP-1α, and macrophage-specific surface glycoprotein F4/80 in diabetic mice. In addition, the protein expression levels of NLRP3 inflammasome components NLRP3, ASC, and caspase-1 (P20) were higher in db/db mice than in wild-type controls. CONCLUSIONS: WMW inhibits the activation of the NLRP3 inflammasome to protect pancreatic β cells and prevent type 2 diabetes mellitus development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-019-2443-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-31 /pmc/articles/PMC6357370/ /pubmed/30704457 http://dx.doi.org/10.1186/s12906-019-2443-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yang, Xueping
Lu, Fuer
Li, Lingli
Li, Jingbin
Luo, Jinlong
Zhang, Siyi
Liu, Xinqiao
Chen, Guang
Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title_full Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title_fullStr Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title_full_unstemmed Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title_short Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
title_sort wu-mei-wan protects pancreatic β cells by inhibiting nlrp3 inflammasome activation in diabetic mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357370/
https://www.ncbi.nlm.nih.gov/pubmed/30704457
http://dx.doi.org/10.1186/s12906-019-2443-6
work_keys_str_mv AT yangxueping wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT lufuer wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT lilingli wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT lijingbin wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT luojinlong wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT zhangsiyi wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT liuxinqiao wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice
AT chenguang wumeiwanprotectspancreaticbcellsbyinhibitingnlrp3inflammasomeactivationindiabeticmice